<b>Methods:</b> Clinical data on children with RUNX1::RUNX1T1-positive AML with KIT mutations who received avapritinib at the Department of Pediatrics, Peking University People's Hospital, from September 2022 to June 2025 were collected. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.